Valeant Pharmaceuticals International has announced the sale of its subsidiary Dendreon Pharmaceuticals for $819.9m to Sanpower Group.

The divestiture is part of the Canadian company’s plans to simplify its business and reduce debt.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

ImmunoPrecise Antibodies has announced the private placement of four million shares priced at C$1 ($0.77) each to raise C$4m ($3.08m).

ImmunoPrecise is a Canadian-based provider of antibodies that plans to use the funds to acquire U-Protein Express.

Pharmaceutical Technology Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Pharmaceutical Technology Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving pharmaceutical advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now